GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark receives ANDA approval for Apremilast Tablets17-10-2023
17-10-2023
Glenmark Pharma's subsidiary licenses OX40 antibodies to Astria, shares up
The shares were up by 1.15 per cent to 789.80 in early trade12-10-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Ichnos Sciences Enters Licensing Agreement For OX40 Antagonist Monoclonal Antibody Portfolio with Astria Therapeutics12-10-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement of Postal Ballot Notice09-10-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Intimation regarding Postal Ballot Notice06-10-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Board Meeting Outcome for Outcome Of The Board Meeting Held On October 05, 2023
The Board of Directors of the Company at its meeting held today, October 05, 2023 have decided to seek the consent of the Members by way of special resolution through Postal Ballot Process for the following: 1. To consider and approve the Sale of Equity Shares of Glenmark Life Sciences Limited, a material subsidiary of the Company. The Board of Directors have appointed Mr. Surjan Singh Rauthan, Practicing Company Secretary, who has given his consent to act as the Scrutinizer, for conducting Postal Ballot process in fair and transparent manner. The meeting commenced at 05:00 p.m. IST and concluded at 05:29 p.m. IST.05-10-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Credit Rating
Rating rationale issued by India Ratings and Research.03-10-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Proceedings and Scrutinizer''s Report of the 45th Annual General Meeting of the Company held on September 29, 2023.29-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings and Scrutinizer''s Report of the 45th Annual General Meeting of the Company held on September 29, 2023.29-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Credit Rating
CRISIL Rating Rationale28-09-2023